Capricor Therapeutics
CAPR
#7633
Rank
โ‚น40.89 B
Marketcap
โ‚น703.29
Share price
0.80%
Change (1 day)
36.52%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: โ‚น40.89 Billion

As of November 2026 Capricor Therapeutics has a market cap of โ‚น40.89 Billion. This makes Capricor Therapeutics the world's 7633th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น40.89 B-70.99%
2025โ‚น140.93 B161.17%
2024โ‚น53.96 B330.48%
2023โ‚น12.53 B55.48%
2022โ‚น8.06 B52.86%
2021โ‚น5.27 B2.18%
2020โ‚น5.16 B981.8%
2019โ‚น0.47 B-46.97%
2018โ‚น0.89 B-65.31%
2017โ‚น2.59 B-32.94%
2016โ‚น3.86 B16.5%
2015โ‚น3.32 B19.33%
2014โ‚น2.78 B18.56%
2013โ‚น2.34 B1943.76%
2012โ‚น0.11 B-89.97%
2011โ‚น1.14 B18.99%
2010โ‚น0.96 B-36.73%
2009โ‚น1.52 B54.13%
2008โ‚น0.98 B-81.03%
2007โ‚น5.20 B3789.04%
2006โ‚น0.13 B-39.43%
2005โ‚น0.22 B3.91%
2004โ‚น0.21 B21.23%
2003โ‚น0.17 B-65.41%
2002โ‚น0.50 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of Capricor Therapeutics was reported to be:

โ‚น40.89 Billion
by Nasdaq info icon info icon
โ‚น40.89 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น60.331 T 147,442.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น1.412 T 3,353.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚น655.46 B 1,502.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น199.56 B 388.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น0.75 B-98.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.21 B-99.48%๐Ÿ‡บ๐Ÿ‡ธ USA